In the past decades, cytokines and cytokine receptors have been extensively studied as cancer targets or cancer therapy by enhancing the growth inhibitory and immunostimulatory effects of interferons and interleukins, such as IL-2, IL-7, IL -12 and IL-15, or by inhibiting the inflammatory and tumor-promoting effects of cytokines such as TNF, IL-1β and IL-6 (10). The gene discussed is IL6; the disease is cancer.